AELIS — Aelis Farma SA Income Statement
0.000.00%
Last trade - 00:00- €16.24m
- €7.46m
- €9.05m
Annual income statement for Aelis Farma SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0 | 0 | 9.07 | 3.81 | 9.05 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 2.99 | 2.84 | 6.52 | 12.3 | 15.5 |
| Operating Profit | -2.99 | -2.84 | 2.55 | -8.53 | -6.46 |
| Total Net Non Operating Interest Income / Expense | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -3.17 | -3.04 | 1.76 | -14.3 | -5.08 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -3.17 | -2.09 | 0.574 | -14.3 | -5.08 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -3.17 | -2.09 | 0.574 | -14.3 | -5.08 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -3.17 | -2.09 | 0.574 | -14.3 | -5.08 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.254 | -0.167 | 0.046 | -1.14 | -0.394 |
| Dividends per Share |